Circulating tumor DNA (ctDNA) is a blood test that can be used to detect and monitor thoracic malignancies. It is being used to detect mutations, monitor for recurrence after surgery and other treatments, and can even be used in conjunction with screening to help identify malignancy. As the field continues to advance, it is crucial for thoracic surgeons, trainees, and healthcare providers to stay informed about the latest developments in ctDNA testing and its applications for thoracic patients.
The latest techniques and management strategies in cardiovascular and thoracic critical care and enhanced recovery after surgery for the entire care team.
Learn how to take advantage of everything the STS Annual Meeting has to offer, from educational sessions and networking opportunities. Special focus will be given to trainees and first-time attendees.
The premier annual event in cardiothoracic surgery, unveiling never-before-seen science, techniques, and technology, and creating a forum to build lasting connections with colleagues.
An expert panel discusses findings and recommendations from a new guideline on patient blood management developed by STS and three other medical specialty organizations.
Michael A. Maddaus, MD, moderates a panel of game changers in the high-performance and wellness space, including a cardiothoracic surgeon, a former Navy Seal, and a clinical psychologist.
Joseph E. Bavaria, MD, and an expert panel engage in a lively and robust debate on takeaways from three recent and very prominent adult cardiac surgery manuscripts.
